Health and Healthcare
How ReWalk Is Capitalizing on Its Big Win
Published:
Last Updated:
ReWalk Robotics Ltd. (NASDAQ: RWLK) shares took a step back on Monday after the firm announced that it would be pricing a registered direct offering for $5 million. This comes after the stock had a phenomenal week when the U.S. Food and Drug Administration (FDA) cleared ReWalk’s ReStore soft exo-suit system.
According to the firm, it has entered into definitive agreements with institutional investors providing for the issuance of approximately 833,334 shares at a purchase price of $6.00 per share in a registered direct offering priced at-the-market.
ReWalk also will issue unregistered warrants to purchase up to approximately 416,667 ordinary shares. The warrants will have a term of 5.5 years, be exercisable immediately following the issuance date and have an exercise price of $6.00 per ordinary share.
Note that this offering is expected to result in gross proceeds of approximately $5 million.
Shares of ReWalk were last seen down about 15% at $5.82, in a 52-week range of $2.46 to $33.75. The consensus price target is $4.00.
Credit Card Companies Are Doing Something Nuts
Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.
It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.
We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
